deucravacitinib,apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra', '$bmy']
$bmy u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis 
Be the First to Know Which #PennyStocks Are Being Promoted - Not the Last! Real-Time #StockAlert Tracking and Monitoring: https://t.co/WLRj8z0R5p